Effect Of Sensitization Programme Regarding Hpv Screening With Self Sampling Method (SSM) Vs Assisted Sampling Method (ASM) On The Level Of Awareness, Among The Women At The Selected Villages Of Puducherry – Pilot Study Report
Main Article Content
Abstract
The cervical cancer screening is very low (22% to 36%) in India among women. Hpv testing has been shown to be more sensitive than a pap smear exam. Several shreds of evidence proved that self-collection of samples for cervical cancer screening can increase participation and follow-up as well. Women may feel more feasible to collect their own samples, rather than going to visit a health worker for cervical cancer screening.
Objectives
- To assess the existing level of awareness on hpv screening among group I (Self Sampling Method) & group II (Assisted Sampling Method) women at the selected Villages of Puducherry.
Methodology
- Quantitative research approach and Quasi experimental design was adopted in this study. Simple random sampling Technique was adopted to select the sample for the study. Total 20 Samples - 10 for experimental group and 10 for control group were selected .
Result and Findings: Regarding demographic variable the study findings are: majority 40% and 70% of women were in the age group of 25-35yrs and 36-45yrs in the group I and II respectively.
With regard to level of awareness the mean pre and posttest level of Awareness in the group I shows that during pretest the mean was 6.1 with SD 4.23 whereas during post test mean is 17.8 with SD 2.14. The mean difference was 10.3 with t value 6.65 shows highly significant.
Similarly in the group II the mean level of Awareness was 2.1 with SD 2.66 and the mean of post test is 6.1 with 3.17. The mean difference was 4 with t value 13.41 which is not significant.
Conclusion: This highlights awareness increased in the group I after the sensitization programme more than Group II.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Bruni, Laia et al.The Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis Lancet Global Health, Volume 10, Issue 8, e1115 - e1127.
Nwabichie, C. C., Manaf, R. A., & Ismail, S. B. (2018). Factors Affecting Uptake of Cervical Cancer Screening Among African Women in Klang Valley, Malaysia. Asian Pacific journal of cancer prevention : APJCP, 19(3), 825–831. https://doi.org/10.22034/APJCP.2018.19.3.825
Siddharthar J, Rajkumar B, Deivasigamani K. Knowledge, awareness and prevention of cervical cancer among women attending a tertiary care hospital in puducherry, India. J Clin Diagn Res 2014;8:OC01‑3.
Driscoll SD. Barriers and facilitators to cervical cancer screening in high incidence populations: A synthesis of qualitative evidence. Women Health 2016;56:448‑67.
Institute National du Cancer. La situation du cancer en France. 2012.
Haute Autorité de Santé. Etat des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France. 2010.
Patra S, Upadhyay M, Chhabra P. Awareness of cervical cancer and willingness to participate in screening program: Public health policy implications. J Cancer Res Ther 2017;13:318-23.
Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol. 2016;37(4):278–85.
Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer. 2013;133(11):2681–7.
Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer. 2013;133(11):2681–7.
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4. Erratum in: Lancet Glob Health. 2022 Jan;10(1):e41. PMID: 31812369; PMCID: PMC7025157.
World Health Organization. (2020). WHO recommendations on self-care interventions: human papillomavirus (HPV) self-sampling as part of cervical cancer screening. World Health Organization. https://apps.who.int/iris/handle/10665/332333. License: CC BY-NC-SA 3.0 IGO
Kumar MS, Shanmugapriya PC, Kaur P. Acceptance of cervical and breast cancer screening and cancer awareness among women in Villupuram, Tamil Nadu, India: A cross sectional survey. Clin Epidemiol Glob Heal 2015;3:S63-8. Available from: https://www.ceghonline.com/article/S2213-3984(15)00075-5/fulltext.
Yeh PT, Kennedy CE, de Vuyst H, et al. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Global Health 2019;4:e001351. doi:10.1136/ bmjgh-2018-001351
Hawkes D, Keung MHT, Huang Y, McDermott TL, Romano J, Saville M, Brotherton JML. Self-Collection for Cervical Screening Programs: From Research to Reality. Cancers (Basel). 2020 Apr 24;12(4):1053. doi: 10.3390/cancers12041053. PMID: 32344565; PMCID: PMC7226191.